A Trial of Neuroprotection With ACTH in Acute Optic Neuritis
Condition(s):Multiple SclerosisLast Updated:April 27, 2023Terminated
Hide Studies Not Open or Pending
Condition(s):Multiple SclerosisLast Updated:April 27, 2023Terminated
Condition(s):Thyroid Eye DiseaseLast Updated:January 10, 2022Withdrawn
Condition(s):Anemia, Hemolytic, AutoimmuneLast Updated:September 10, 2013Completed
Condition(s):Progression of Rheumatoid ArthritisLast Updated:April 10, 2020Completed
Condition(s):Aplastic Anemia; de Novo Myelodysplastic Syndrome; Myelodysplastic Syndrome; Previously Treated Myelodysplastic SyndromeLast Updated:March 9, 2023Recruiting
Condition(s):SARS-CoV2 Infection; COVID-19Last Updated:March 9, 2023Withdrawn
Condition(s):Breast CancerLast Updated:June 27, 2011Unknown status
Condition(s):Adrenal InsufficiencyLast Updated:December 6, 2022Recruiting
Condition(s):Cataracts; Corneal Edema; Retinal Structural Change, Deposit and Degeneration; Visual Acuity Reduced TransientlyLast Updated:August 8, 2012Completed
Condition(s):Epiphora Due to Insufficient DrainageLast Updated:March 24, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.